Elon Musk’s Neuralink may have just secured $205 million in Series C funding, but there’s another brain-computer interface in the news that is pulling ahead in the race to market. According to a recent Bloomberg Quint article, New York-based Synchron Inc. received the FDA’s green light to begin human trials to determine if their implants work safely and could eventually be sold in the U. S.
This Brain Computer Startup Beat Neuralink to FDA Trials
The announcement moves Synchron Inc. ahead of Elon Musk’s company in the race to market.
Aug 6, 2021
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More